99% Pyrroloquinoline Quinone Powder PQQ

• Customization: Available
• Certification: ISO, Halal
• Assay Method: HPLC-MS, HPLC
• Model NO.: NY029
• Application Form: Tablet, Capsule, Softgels, Tinctures, Liquids, Drops
• Application: Health Care Products, Medicine
• State: Powder
• Extract Source: Fermentation Extraction
• Lead Time: 5 Days
• Color: Red Brown Powder
• Transport Package: 25kg/Drum
• Specification: 99%
• Trademark: Nutrayours/ OEM
• Origin: China
• HS Code: 1302199099
• Production Capacity: 3000kg/Year

Product Description

 

About this item

 

• 100% NATURAL PRODUCT: No artificial colors or flavors
• Verified herb identity, confirmed highest quality of raw herb and the extract
• Best natural sources of herbs and raw materials: Every vendor is carefully picked to meet our high standards
• Third-party lab tested, pure Pyrroloquinoline quinone disodium Salt (PQQ)

     Pyrroloquinoline quinone disodium has anti-inflammatory, antioxidant, anti-tumor, immunomodulatory, anti-platelet aggregation, antibacterial and anti-parasitic effects. These effects make PQQ a potential clinical application in the treatment of inflammatory diseases, oxidative stress-related diseases, tumors, immune system related diseases, thrombotic diseases, bacterial infections and parasitic infections.

    At present, the common PQQ supplement products on the market are mainly for brain health, sleep aid, energy supplement, oral beauty, pregnancy aid and other aspects, often used with MNM, coenzyme Q10, ginkgo biloba extract, PS and other raw materials.

Keywords:disodium4,5-dihydro-4,5-dioxo-1h-pyrrolo(2,3-f)quinoline-2,7,9-tricarboxylat;PQQ, Pyrrolo-quinoline-quinone disodium salt;sodiuM 9-carboxy-4,5-dioxo-4,5-dihydro-1H- pyrrolo[2,3-f]quinoline-2,7-dicarboxylate;PQQ disodium;1H-Pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylicacid, 4,5-dihydro-4,5-dioxo-, sodiumsalt

About us

* The statements in this section have not been evaluated by the FDA or EFSA.

References

    1.Tamakoshi M, Suzuki T, Nishihara E, Nakamura S, Ikemoto K.Food Funct. 2023 Mar 6;14(5):2496-2501. doi: 10.1039/d2fo01515c.PMID: 36807425 
    2.Shiojima Y, Takahashi M, Takahashi R, Moriyama H, Bagchi D, Bagchi M, Akanuma M.J Am Nutr Assoc. 2022 Nov-Dec;41(8):796-809. doi: 10.1080/07315724.2021.1962770. Epub 2021 Aug 20.PMID: 34415830 
    3.Nakano M, Suzuki H, Imamura T, Lau A, Lynch B.Regul Toxicol Pharmacol. 2013 Nov;67(2):189-97. doi: 10.1016/j.yrtph.2013.07.007. Epub 2013 Jul 25.PMID: 23891671
    4.Shiojima Y, Deshmukh N, Moriyama H, Soman Y, Nalge P, Randhe M, Kanhere J, Karmarkar A, Bagchi M, Bagchi D.Toxicol Mech Methods. 2022 Nov;32(9):662-677. doi: 10.1080/15376516.2022.2076635. Epub 2022 Jun 21.PMID: 35546737
    5.Shiojima Y, Deshmukh N, Moriyama H, Soman Y, Nalge P, Randhe M, Kanhere J, Karmarkar A, Bagchi M, Bagchi D.Toxicol Mech Methods. 2022 Nov;32(9):662-677. doi: 10.1080/15376516.2022.2076635. Epub 2022 Jun 21.PMID: 35546737